Nurse Practitioner, Family · Biloxi, MS
NPI
1255767844
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1025 Division St Ste B1
Biloxi, MS, 39530
Phone (228) 235-9550
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
1,087 services
Medicare patients, 2024
310
Average age 72
Drug cost, 2024
$4.6M
2,531 prescriptions
Company payments, 2025
$1,718
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thu T Tran was code 99214 (office e&m - established), 491 times for 263 patients. In total Thu T Tran billed 1,087 services in 10 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 491 | 263 | $56.55 | $28K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 433 | 246 | $10.08 | $4,366 |
| 99214 Office E&M - Established | Office | 51 | 45 | $48.22 | $2,459 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 39 | 39 | $9.38 | $366 |
| 99215 Office E&M - Established | Facility | 18 | 16 | $84.88 | $1,528 |
| 99213 Office E&M - Established | Office | 18 | 17 | $30.09 | $542 |
| 99213 Office E&M - Established | Facility | 13 | 13 | $28.36 | $369 |
By year: 2022 $19K for 469 services; 2023 $28K for 626 services; 2024 $38K for 1,087 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thu T Tran prescribed most often to Medicare patients was Prednisone, with 528 prescriptions and refills. In total Thu T Tran wrote 2,531 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 528 | 770 | 221 | $3,850 |
| Hydroxychloroquine Sulfate Generic | 312 | 814 | 99 | $13K |
| Orencia Clickject Abatacept | 146 | 158 | 20 | $833K |
| Gabapentin Generic | 136 | 280 | 46 | $1,371 |
| Humira(Cf) Pen Adalimumab | 130 | 136 | 22 | $868K |
| Sulfasalazine Dr Sulfasalazine | 119 | 222 | 37 | $4,857 |
| Methotrexate Methotrexate Sodium | 115 | 242 | 35 | $1,427 |
| Enbrel Mini Etanercept | 101 | 101 | 21 | $727K |
| Cimzia (2 Pack) Certolizumab Pegol | 90 | 90 | 12 | $489K |
| Enbrel Sureclick Etanercept | 88 | 88 | 16 | $638K |
| Duloxetine Hcl Generic | 66 | 130 | 21 | $873 |
| Pilocarpine Hcl Generic | 49 | 115 | 16 | $3,917 |
| Allopurinol Generic | 47 | 111 | 12 | $622 |
| Cyclobenzaprine Hcl Generic | 37 | 42 | 17 | $118 |
| Leflunomide Generic | 28 | 56 | 12 | $1,335 |
Brand drugs: - claims; generic drugs: 1,619 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thu T Tran $1,718 ($1,718 in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $275.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 19 | $275 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $208 |
| Abbvie Inc. ABBV | 12 | $202 |
| Janssen Biotech, Inc. JNJ | 8 | $184 |
| Pfizer Inc. PFE | 5 | $110 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $99.33 |
| GlaxoSmithKline, LLC. GSK | 3 | $83.84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $83.07 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $68.88 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $68.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.